SitesBLAST
Comparing WP_068169482.1 NCBI__GCF_001592305.1:WP_068169482.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
Q8NMB0 Vanillin dehydrogenase; Aromatic aldehyde dehydrogenase; EC 1.2.1.67; EC 1.2.1.64; EC 1.2.1.96 from Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / BCRC 11384 / CCUG 27702 / LMG 3730 / NBRC 12168 / NCIMB 10025 / NRRL B-2784 / 534) (see paper)
44% identity, 92% coverage: 31:477/486 of query aligns to 33:481/484 of Q8NMB0
- N157 (= N155) mutation to A: Less than 50% of the activity of the wild-type with vanillin as substrate in the presence of NAD(+). Less than 10% of the activity of the wild-type with vanillin as substrate in the presence of NADP(+). 4.5-fold decreased affinity for NAD(+), 11-fold decreased affinity for NADP(+) and 2.3-fold decreased affinity for vanillin compared to the wild type.
- K180 (= K178) mutation to A: Less than 50% of the activity of the wild-type with vanillin as substrate in the presence of NAD(+). Less than 10% of the activity of the wild-type with vanillin as substrate in the presence of NADP(+). 4.5-fold decreased affinity for NAD(+), 11-fold decreased affinity for NADP(+) and 5-fold decreased affinity for vanillin compared to the wild type.
- E199 (≠ D197) mutation to A: Less than 50% of the activity of the wild-type with vanillin as substrate in the presence of NAD(+). 78% of the activity of the wild-type with vanillin as substrate in the presence of NADP(+). 5-fold decreased affinity for NAD(+), 2.5-fold decreased affinity for NADP(+) and 1.5-fold decreased affinity for vanillin compared to the wild type.
- E258 (= E253) mutation to A: Less than 50% of the activity of the wild-type with vanillin as substrate in the presence of NAD(+). 24% of the activity of the wild-type with vanillin as substrate in the presence of NADP(+). 3.5-fold decreased affinity for NAD(+), 5-fold decreased affinity for NADP(+) and 3.7-fold decreased affinity for vanillin compared to the wild type.
- C292 (= C287) mutation to A: Less than 50% of the activity of the wild-type with vanillin as substrate in the presence of NAD(+). Less than 10% of the activity of the wild-type with vanillin as substrate in the presence of NADP(+). 4.5-fold decreased affinity for NAD(+), 7-fold decreased affinity for NADP(+) and 8-fold decreased affinity for vanillin compared to the wild type.
5ek6A Thermostable aldehyde dehydrogenase from pyrobaculum sp. 1860 complexed with NADP and isobutyraldehyde (see paper)
37% identity, 96% coverage: 21:485/486 of query aligns to 13:477/482 of 5ek6A
- active site: N147 (= N155), K170 (= K178), E245 (= E253), C279 (= C287), E374 (= E381), E452 (≠ F460)
- binding 2-methylpropanal: I152 (≠ L160), K155 (≠ R163), T222 (= T230), E245 (= E253), F441 (= F448)
- binding nadp nicotinamide-adenine-dinucleotide phosphate: I143 (= I151), T144 (≠ A152), W146 (= W154), N147 (= N155), I152 (≠ L160), K170 (= K178), A172 (≠ D180), S173 (≠ A181), P202 (vs. gap), G203 (= G211), G207 (= G215), F221 (= F229), T222 (= T230), G223 (= G231), E224 (≠ S232), T227 (≠ V235), I231 (= I239), E245 (= E253), L246 (= L254), C279 (= C287), E374 (= E381)
4h73A Thermostable aldehyde dehydrogenase from pyrobaculum sp. Complexed with NADP+
37% identity, 96% coverage: 21:485/486 of query aligns to 13:477/482 of 4h73A
- active site: N147 (= N155), K170 (= K178), E245 (= E253), C279 (= C287), E374 (= E381), E452 (≠ F460)
- binding nadph dihydro-nicotinamide-adenine-dinucleotide phosphate: I143 (= I151), T144 (≠ A152), P145 (= P153), W146 (= W154), K170 (= K178), A172 (≠ D180), S173 (≠ A181), G203 (= G211), G207 (= G215), F221 (= F229), G223 (= G231), E224 (≠ S232), T227 (≠ V235)
5ekcE Thermostable aldehyde dehydrogenase from pyrobaculum sp.1860 complexed with NADP+
37% identity, 96% coverage: 21:485/486 of query aligns to 20:484/490 of 5ekcE
- active site: N154 (= N155), K177 (= K178), E252 (= E253), C286 (= C287), E381 (= E381), E459 (≠ F460)
- binding nadp nicotinamide-adenine-dinucleotide phosphate: I150 (= I151), T151 (≠ A152), P152 (= P153), W153 (= W154), K177 (= K178), S180 (≠ A181), G210 (= G211), G214 (= G215), F228 (= F229), G230 (= G231), E231 (≠ S232), T234 (≠ V235), N331 (= N331), R333 (≠ K333), Q334 (= Q334)
1bpwA Betaine aldehyde dehydrogenase from cod liver (see paper)
36% identity, 93% coverage: 26:477/486 of query aligns to 38:494/503 of 1bpwA
- active site: N166 (= N155), K189 (= K178), E263 (= E253), C297 (= C287), E400 (= E381), E477 (≠ F460)
- binding nicotinamide-adenine-dinucleotide: I162 (= I151), L163 (≠ A152), W165 (= W154), N166 (= N155), K189 (= K178), G221 (= G211), G225 (= G215), T240 (= T230), G241 (= G231), S242 (= S232), T245 (≠ V235), E263 (= E253), L264 (= L254), C297 (= C287), E400 (= E381), F402 (= F383), F466 (= F448)
P56533 4-trimethylaminobutyraldehyde dehydrogenase; TMABA-DH; TMABADH; Aldehyde dehydrogenase family 9 member A1; Betaine aldehyde dehydrogenase; BADH; EC 1.2.1.47; EC 1.2.1.3 from Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) (see paper)
36% identity, 93% coverage: 26:477/486 of query aligns to 38:494/503 of P56533
4jz6A Crystal structure of a salicylaldehyde dehydrogenase from pseudomonas putida g7 complexed with salicylaldehyde (see paper)
32% identity, 98% coverage: 12:486/486 of query aligns to 5:484/484 of 4jz6A
- active site: N150 (= N155), K173 (= K178), E251 (= E253), C285 (= C287), E380 (= E381), F458 (= F460)
- binding salicylaldehyde: W97 (≠ K102), G151 (≠ F156), V154 (≠ L159), R247 (≠ K249), C248 (≠ V250), I284 (= I286), C285 (= C287), M286 (= M288), Y447 (≠ F448), Y455 (≠ N456)
6vr6D Structure of aldh9a1 complexed with NAD+ in space group p1 (see paper)
33% identity, 94% coverage: 22:477/486 of query aligns to 24:484/493 of 6vr6D
- active site: N156 (= N155), E253 (= E253), C287 (= C287), E467 (≠ F460)
- binding nicotinamide-adenine-dinucleotide: I152 (= I151), G153 (≠ A152), W155 (= W154), K179 (= K178), A212 (≠ P212), G215 (= G215), Q216 (≠ D216), F229 (= F229), G231 (= G231), S232 (= S232), T235 (≠ V235), I239 (= I239)
P49189 4-trimethylaminobutyraldehyde dehydrogenase; TMABA-DH; TMABALDH; Aldehyde dehydrogenase E3 isozyme; Aldehyde dehydrogenase family 9 member A1; Formaldehyde dehydrogenase; Gamma-aminobutyraldehyde dehydrogenase; R-aminobutyraldehyde dehydrogenase; EC 1.2.1.47; EC 1.2.1.3; EC 1.2.1.46; EC 1.2.1.19 from Homo sapiens (Human) (see 2 papers)
33% identity, 94% coverage: 22:477/486 of query aligns to 25:485/494 of P49189
- C116 (≠ Q113) to S: in allele ALDH9A1*2
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed; alternate
- 2 modified: N-acetylserine; in 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed
8of1A Structure of aldh5f1 from moss physcomitrium patens in complex with NAD+ in the contracted conformation
35% identity, 97% coverage: 13:482/486 of query aligns to 31:504/505 of 8of1A
- binding nicotinamide-adenine-dinucleotide: I170 (= I151), A171 (= A152), P172 (= P153), W173 (= W154), K197 (= K178), A230 (≠ P212), F248 (= F229), G250 (= G231), S251 (= S232), V254 (= V235), M257 (≠ S238), L273 (= L254), C306 (= C287), K356 (≠ R337), E403 (= E381), F405 (= F383)
6tgwA Crystal structure of human aldehyde dehydrogenase 1a3 in complex with a selective inhibitor (see paper)
34% identity, 96% coverage: 12:477/486 of query aligns to 7:476/478 of 6tgwA
- active site: N155 (= N155), E254 (= E253), C288 (= C287), E459 (≠ R459)
- binding methyl 5-(1,3-benzodioxol-5-yl)-2-phenyl-pyrazolo[1,5-a]pyrimidine-7-carboxylate: I106 (vs. gap), G110 (≠ A109), F156 (= F156), Q278 (≠ W277), F282 (≠ L281), L442 (≠ E443), A444 (vs. gap)
- binding nicotinamide-adenine-dinucleotide: I151 (= I151), T152 (≠ A152), P153 (= P153), W154 (= W154), K178 (= K178), G211 (= G211), G215 (= G215), F229 (= F229), G231 (= G231), S232 (= S232), V235 (= V235)
O94788 Retinal dehydrogenase 2; RALDH 2; RalDH2; Aldehyde dehydrogenase family 1 member A2; ALDH1A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II); EC 1.2.1.36 from Homo sapiens (Human) (see 6 papers)
35% identity, 96% coverage: 12:477/486 of query aligns to 39:511/518 of O94788
- E50 (≠ A22) to G: in dbSNP:rs34266719
- A110 (= A78) to V: in dbSNP:rs35365164
- Q182 (≠ V150) to K: in DIH4; decreased retinoic acid biosynthetic process
- IPW 184:186 (≠ APW 152:154) binding NAD(+)
- KPAE 210:213 (≠ KPDA 178:181) binding NAD(+)
- STE 264:266 (≠ STA 232:234) binding NAD(+)
- C320 (= C287) active site, Nucleophile
- R347 (≠ L314) to H: in DIH4; decreased expression; dbSNP:rs141245344
- V348 (≠ Y315) to I: in dbSNP:rs4646626
- KQYNK 366:370 (≠ KQCNR 333:337) binding NAD(+)
- A383 (= A350) to T: in DIH4; uncertain significance; dbSNP:rs749124508
- E417 (= E381) binding NAD(+)
- E436 (= E400) to K: in dbSNP:rs34744827
- S461 (≠ A425) to Y: in DIH4; decreased retinoic acid biosynthetic process
6b5hA Aldh1a2 liganded with NAD and 1-(4-cyanophenyl)-n-(3-fluorophenyl)-3- [4-(methylsulfonyl)phenyl]-1h-pyrazole-4-carboxamide (compound cm121) (see paper)
35% identity, 96% coverage: 12:477/486 of query aligns to 13:485/492 of 6b5hA
- active site: N161 (= N155), E260 (= E253), C294 (= C287), E468 (≠ F460)
- binding 1-(4-cyanophenyl)-N-(3-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]-1H-pyrazole-4-carboxamide: V112 (vs. gap), G116 (≠ A109), F162 (= F156), W169 (≠ R163), Q284 (≠ W277), F288 (≠ L281), T295 (≠ M288), N449 (≠ T439), L451 (≠ N441), N452 (= N442), F457 (= F448)
- binding nicotinamide-adenine-dinucleotide: I157 (= I151), I158 (≠ A152), W160 (= W154), N161 (= N155), K184 (= K178), G217 (= G211), G221 (= G215), F235 (= F229), T236 (= T230), G237 (= G231), S238 (= S232), V241 (= V235), E260 (= E253), L261 (= L254), C294 (= C287), F393 (= F383)
6b5gA Aldh1a2 liganded with NAD and (3-ethoxythiophen-2-yl){4-[4-nitro-3- (pyrrolidin-1-yl)phenyl]piperazin-1-yl}methanone (compound 6-118) (see paper)
35% identity, 96% coverage: 12:477/486 of query aligns to 13:485/492 of 6b5gA
- active site: N161 (= N155), E260 (= E253), C294 (= C287), E468 (≠ F460)
- binding (3-ethoxythiophen-2-yl){4-[4-nitro-3-(pyrrolidin-1-yl)phenyl]piperazin-1-yl}methanone: F162 (= F156), L165 (= L159), W169 (≠ R163), F288 (≠ L281), C293 (≠ I286), C294 (= C287), T295 (≠ M288), N449 (≠ T439), L451 (≠ N441)
- binding nicotinamide-adenine-dinucleotide: I157 (= I151), I158 (≠ A152), P159 (= P153), W160 (= W154), N161 (= N155), M166 (≠ L160), K184 (= K178), E187 (≠ A181), G217 (= G211), G221 (= G215), F235 (= F229), T236 (= T230), G237 (= G231), S238 (= S232), V241 (= V235), E260 (= E253), L261 (= L254), C294 (= C287), E391 (= E381), F393 (= F383)
6aljA Aldh1a2 liganded with NAD and compound win18,446 (see paper)
35% identity, 96% coverage: 12:477/486 of query aligns to 13:485/492 of 6aljA
- active site: N161 (= N155), E260 (= E253), C294 (= C287), E468 (≠ F460)
- binding N,N'-(octane-1,8-diyl)bis(2,2-dichloroacetamide): G116 (≠ A109), F162 (= F156), L165 (= L159), M166 (≠ L160), W169 (≠ R163), E260 (= E253), C293 (≠ I286), C294 (= C287), L451 (≠ N441), N452 (= N442), A453 (≠ E443)
- binding nicotinamide-adenine-dinucleotide: I157 (= I151), I158 (≠ A152), P159 (= P153), W160 (= W154), N161 (= N155), K184 (= K178), E187 (≠ A181), G217 (= G211), G221 (= G215), F235 (= F229), G237 (= G231), S238 (= S232), V241 (= V235), Q341 (= Q334), K344 (≠ R337), E391 (= E381), F393 (= F383)
Q63639 Retinal dehydrogenase 2; RALDH 2; RalDH2; Aldehyde dehydrogenase family 1 member A2; ALDH1A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II); EC 1.2.1.36 from Rattus norvegicus (Rat) (see paper)
35% identity, 96% coverage: 12:477/486 of query aligns to 39:511/518 of Q63639
7a6qB Crystal structure of human aldehyde dehydrogenase 1a3 in complex with selective nr6 inhibitor compound (see paper)
34% identity, 96% coverage: 12:477/486 of query aligns to 15:487/489 of 7a6qB
- active site: N163 (= N155), E262 (= E253), C296 (= C287), E470 (≠ R459)
- binding nicotinamide-adenine-dinucleotide: I159 (= I151), W162 (= W154), K186 (= K178), E189 (≠ A181), G219 (= G211), G223 (= G215), S240 (= S232), V243 (= V235), K342 (= K333)
- binding (3-oxidanylidene-3-sodiooxy-propanoyl)oxysodium: A32 (= A27), T33 (≠ V28), C34 (≠ R29), P36 (= P31), D103 (≠ E95), E189 (≠ A181), Q190 (= Q182), F218 (vs. gap), I339 (= I330), D340 (≠ N331)
- binding 3-(2-phenylimidazo[1,2-a]pyridin-6-yl)benzenecarbonitrile: G118 (≠ A109), D141 (≠ S132), N143 (≠ G135), N451 (= N441), L453 (≠ E443), A455 (vs. gap)
7a6qA Crystal structure of human aldehyde dehydrogenase 1a3 in complex with selective nr6 inhibitor compound (see paper)
34% identity, 96% coverage: 12:477/486 of query aligns to 15:487/489 of 7a6qA
- active site: N163 (= N155), E262 (= E253), C296 (= C287), E470 (≠ R459)
- binding nicotinamide-adenine-dinucleotide: I159 (= I151), T160 (≠ A152), W162 (= W154), K186 (= K178), A188 (≠ D180), E189 (≠ A181), G219 (= G211), G223 (= G215), S240 (= S232), V243 (= V235), K342 (= K333), K346 (≠ R337)
- binding 3-(2-phenylimidazo[1,2-a]pyridin-6-yl)benzenecarbonitrile: G118 (≠ A109), D141 (≠ S132), N143 (≠ G135), N451 (= N441), L453 (≠ E443), Y454 (≠ F444)
5fhzA Human aldehyde dehydrogenase 1a3 complexed with NAD(+) and retinoic acid (see paper)
34% identity, 96% coverage: 12:477/486 of query aligns to 15:487/489 of 5fhzA
- active site: N163 (= N155), K186 (= K178), E262 (= E253), C296 (= C287), E393 (= E381), E470 (≠ R459)
- binding nicotinamide-adenine-dinucleotide: I159 (= I151), T160 (≠ A152), W162 (= W154), K186 (= K178), E189 (≠ A181), G219 (= G211), G223 (= G215), F237 (= F229), G239 (= G231), S240 (= S232), T241 (= T233), V243 (= V235), G264 (= G255), Q343 (= Q334), E393 (= E381)
- binding retinoic acid: G118 (≠ A109), R121 (≠ E112), F164 (= F156), M168 (≠ L160), W171 (≠ R163), C295 (≠ I286), C296 (= C287), L453 (≠ E443)
7qk9A Crystal structure of the aldh1a3-atp complex (see paper)
34% identity, 96% coverage: 12:477/486 of query aligns to 14:486/489 of 7qk9A
- binding adenosine-5'-triphosphate: I158 (= I151), T159 (≠ A152), P160 (= P153), W161 (= W154), K185 (= K178), E188 (≠ A181), G218 (= G211), G222 (= G215), F236 (= F229), S239 (= S232), V242 (= V235)
Query Sequence
>WP_068169482.1 NCBI__GCF_001592305.1:WP_068169482.1
MSASSPAIWSGKIFSNGWTDAAGGVQAVREPATGQSLEQTGIANPADVNRAAASAKAARA
AWAATPFDQRAAVMREAARLLKERAADINIWNIRECGSIGPKAEWELHATYEQMLMAAAL
PMQANGQLFPSSMPGRTNLWRRVPMGTVGVIAPWNFPLLLAMRSVAPALALGNAVLLKPD
AQTAVTGGHLIAQVFADAGLPDGVLHVLPGGPETGDAVVRHPDVTMISFTGSTAVGKSIG
ATCGGLLKKVALELGGNNALIVLDDANLDAAASNGAWGAFLHQGQICMQAGRHLVQRKVA
QAYADKLVQRAKALYVGDPHAGPAHLGPIINAKQCNRVQDIVDRSVAQGARLLTGGTHEG
LFFQPTVLSGVTADMPAFADEIFGPVAPITVFDTEDEAVELVNASPYGLAAAIHSANVSR
AMSVANRLHTGMIHVNDQTVNNEFHVPFGGMGASGNGGRFGGPANLDEFTQTQWVSVMEQ
PIVYPF
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory